Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study

PLoS ONE - United States
doi 10.1371/journal.pone.0088177
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma (Dlbcl): A Large Population-Based Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Diffuse Large B-Cell Lymphoma: A Case Report

Clinical and Experimental Health Sciences
2018English

A Retrospective Analysis of Real-World Outcomes of Chinese Elder Patients With Diffuse Large B Cell Lymphoma (Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Ets1 Positively Regulates Faim3 in Activated B Cell-Like (Abc) Diffuse Large B Cell Lymphoma (Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

The Fine Specificity of IgM Anti-Citrullinated Protein Antibodies (ACPA) Is Different From That of IgG ACPA

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2011English

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Sao Paulo Medical Journal
Medicine
2010English

Simultaneous Diffuse Large B-Cell Lymphoma (Dlbcl) and Follicular Lymphoma (Fl) at the Diagnosis Has Similar Outcome as DLBCL

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Diffuse Large B-Cell Lymphoma

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy